newsThe first patient with COVID-19 has been administered agenT-797, an allogeneic cell therapy…
9 November 2020 | By Victoria Rees (European Pharmaceutical Review)
The first patient with COVID-19 has been administered agenT-797, an allogeneic cell therapy made by Agenus Inc.